China Biologic Products (CBPO) Stock Rating Upgraded by BidaskClub
China Biologic Products (NASDAQ:CBPO) was upgraded by analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a report issued on Wednesday.
Separately, Zacks Investment Research upgraded shares of China Biologic Products from a “sell” rating to a “hold” rating in a research note on Wednesday, November 15th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $137.50.
China Biologic Products (CBPO) opened at $77.83 on Wednesday. China Biologic Products has a one year low of $72.21 and a one year high of $120.46. The firm has a market cap of $2,113.22, a price-to-earnings ratio of 17.05, a P/E/G ratio of 1.25 and a beta of 1.78.
COPYRIGHT VIOLATION NOTICE: This piece was first posted by Watch List News and is the sole property of of Watch List News. If you are viewing this piece on another domain, it was illegally copied and reposted in violation of US & international copyright and trademark legislation. The correct version of this piece can be read at https://www.watchlistnews.com/china-biologic-products-cbpo-stock-rating-upgraded-by-bidaskclub/1773744.html.
About China Biologic Products
Receive News & Ratings for China Biologic Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Biologic Products and related companies with MarketBeat.com's FREE daily email newsletter.